The DOI matches its Crossref record; 126 of the 126 references it cites were found in a registry or an index.
Neuroblastoma: biological insights into a clinical enigma
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Khan, J., Wei, J. S., Ringnér, M., Saal, L. H., Ladanyi, M., Westermann, F., Berthold, F., Schwab, M., Antonescu, C. R., Peterson, C., et al. (2001) · Nature Medicine · doi:10.1038/89044 · Cited by 2,644
Brodeur, G. M., Pritchard, J., Berthold, F., Carlsen, N. L., Castel, V, Castelberry, R. P., De Bernardi, B., Evans, A. E., Favrot, M., & Hedborg, F. (1993) · Journal of Clinical Oncology · doi:10.1200/jco.1993.11.8.1466 · Cited by 2,294
Self-citationAmplification of N- myc in Untreated Human Neuroblastomas Correlates with Advanced Disease Stage
Brodeur, G. M., Seeger, R. C., Schwab, M., Varmus, H. E., & Bishop, J. M. (1984) · Science · doi:10.1126/science.6719137 · Cited by 2,262
Self-citationPrinciples and Practice of Pediatric Oncology
(1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-112-8-636_3 · Cited by 2,027
Association of Multiple Copies of the N-myc Oncogene with Rapid Progression of Neuroblastomas
Seeger, R. C., Brodeur, G. M., Sather, H., Dalton, A., Siegel, S. E., Wong, K. Y., & Hammond, D. (1985) · New England Journal of Medicine · doi:10.1056/nejm198510313131802 · Cited by 2,010
Self-citationMatthay, K. K., Villablanca, J. G., Seeger, R. C., Stram, D. O., Harris, R. E., Ramsay, N. K., Swift, P., Shimada, H., Black, C. T., Brodeur, G. M., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199910143411601 · Cited by 1,898
Self-citationSchwab, M., Alitalo, K., Klempnauer, K.-H., Varmus, H. E., Bishop, J. M., Gilbert, F., Brodeur, G., Goldstein, M., & Trent, J. (1983) · Nature · doi:10.1038/305245a0 · Cited by 1,407
Self-citationThe Genetic Basis of Human Cancer
Vogelstein, B., & Kinzler, K. W. (1997) · Cited by 1,120
Trk receptors: mediators of neurotrophin action
Patapoutian, A., & Reichardt, L. F. (2001) · Current Opinion in Neurobiology · doi:10.1016/s0959-4388(00)00208-7 · Cited by 1,069
The International Neuroblastoma Pathology Classification (the Shimada system)
Shimada, H., Ambros, I. M., Dehner, L. P., Hata, J.-I., Joshi, V. V., Roald, B., Stram, D. O., Gerbing, R. B., Lukens, J. N., Matthay, K. K., et al. (1999) · Cancer · doi:10.1002/(sici)1097-0142(19990715)86:2<364::aid-cncr21>3.0.co;2-7 · Cited by 1,067
Principles and Practice of Pediatric Oncology
Labotka, R. J. (2002) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.288.7.894-a · Cited by 1,046
Targeted expression of MYCN causes neuroblastoma in transgenic mice
Weiss, W. A. (1997) · The EMBO Journal · doi:10.1093/emboj/16.11.2985 · Cited by 870
Less is more, regularly: metronomic dosing of cytotoxic drugs can target tumor angiogenesis in mice
Hanahan, D., Bergers, G., & Bergsland, E. (2000) · Journal of Clinical Investigation · doi:10.1172/jci9872 · Cited by 865
Shimada, H., Chatten, J., Newton, W. A., Sachs, N., Hamoudi, A. B., Chiba, T., Marsden, H. B., & Misugi, K. (1984) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/73.2.405 · Cited by 862
A BDNF autocrine loop in adult sensory neurons prevents cell death
Acheson, A., Conover, J. C., Fandl, J. P., DeChiara, T. M., Russell, M., Thadani, A., Squinto, S. P., Yancopoulos, G. D., & Lindsay, R. M. (1995) · Nature · doi:10.1038/374450a0 · Cited by 765
Nakagawara, A., Arima-Nakagawara, M., Scavarda, N. J., Azar, C. G., Cantor, A. B., & Brodeur, G. M. (1993) · New England Journal of Medicine · doi:10.1056/nejm199303253281205 · Cited by 694
Self-citationThiele, C. J., Reynolds, C. P., & Israel, M. A. (1985) · Nature · doi:10.1038/313404a0 · Cited by 642
Molecular Biology of Neuroblastoma
Maris, J. M., & Matthay, K. K. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.7.2264 · Cited by 639
Correlating telomerase activity levels with human neuroblastoma outcomes
Hiyama, E., Hiyama, K., Yokoyama, T., Matsuura, Y., Piatyszek, M. A., & Shay, J. W. (1995) · Nature Medicine · doi:10.1038/nm0395-249 · Cited by 611
Look, A. T., Hayes, F. A., Shuster, J. J., Douglass, E. C., Castleberry, R. P., Bowman, L. C., Smith, E. I., & Brodeur, G. M. (1991) · Journal of Clinical Oncology · doi:10.1200/jco.1991.9.4.581 · Cited by 594
Self-citationShimada, H., Ambros, I. M., Dehner, L. P., Hata, J.-I., Joshi, V. V., & Roald, B. (1999) · Cancer · doi:10.1002/(sici)1097-0142(19990715)86:2<349::aid-cncr20>3.0.co;2-y · Cited by 586
Shimada, H., Ambros, I. M., Dehner, L. P., Hata, J., Joshi, V. V., & Roald, B. (1999) · PubMed · Cited by 573
Look, A. T., Hayes, F. A., Nitschke, R., McWilliams, N. B., & Green, A. A. (1984) · New England Journal of Medicine · doi:10.1056/nejm198407263110405 · Cited by 491
Neuroblastoma Screening at One Year of Age
Schilling, F. H., Spix, C., Berthold, F., Erttmann, R., Fehse, N., Hero, B., Klein, G., Sander, J., Schwarz, K., Treuner, J., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012277 · Cited by 464
The CD95 (APO-1/Fas) system mediates drug-induced apoptosis in neuroblastoma cells.
Fulda, S., Sieverts, H., Friesen, C., Herr, I., & Debatin, K. (1997) · PubMed · Cited by 443
P-Glycoprotein Expression as a Predictor of the Outcome of Therapy for Neuroblastoma
Chan, H. S. L., Haddad, G., Thorner, P. S., DeBoer, G., Lin, Y. P., Ondrusek, N., Yeger, H., & Ling, V. (1991) · New England Journal of Medicine · doi:10.1056/nejm199112053252304 · Cited by 441
Moll, U. M., LaQuaglia, M., Bénard, J., & Riou, G. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.10.4407 · Cited by 427
Allelic Loss of Chromosome 1p as a Predictor of Unfavorable Outcome in Patients with Neuroblastoma
Caron, H. N., Sluis, P. V., de Kraker, J., Bökkerink, J. P. M., Egeler, M., Laureys, G., Slater, R. M., Westerveld, A., Voûte, P. A., & Versteeg, R. (1996) · New England Journal of Medicine · doi:10.1056/nejm199601253340404 · Cited by 425
Expression and function of TRK-B and BDNF in human neuroblastomas.
Nakagawara, A., Azar, C. G., Scavarda, N. J., & Brodeur, G. M. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.1.759 · Cited by 423
Self-citationThe Genetic Basis of Human Cancer
Rubin, C. M. (1998) · Annals of Internal Medicine · doi:10.7326/0003-4819-129-9-199811010-00045 · Cited by 411
IN SITU NEUROBLASTOMAS: A CONTRIBUTION TO THE NATURAL HISTORY OF NEURAL CREST TUMORS.
Jb, B., & Perrin, E. V. (1963) · PubMed · Cited by 403
Fong, C. T., Dracopoli, N. C., White, P. S., Merrill, P. T., Griffith, R. C., Housman, D. E., & Brodeur, G. M. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.10.3753 · Cited by 396
Self-citationIslam, A., Kageyama, H., Takada, N., Kawamato, T., Takayasu, H., Isogai, E., Ohira, M., Hashizume, K., Kobayashi, H., Kaneko, Y., et al. (2000) · Oncogene · doi:10.1038/sj.onc.1203358 · Cited by 386
Cytogenetic features of human neuroblastomas and cell lines.
Brodeur, G. M., Green, A. A., Hayes, F. A., Williams, K. J., Williams, D. L., & Tsiatis, A. A. (1981) · PubMed · Cited by 383
Self-citationScreening of Infants and Mortality Due to Neuroblastoma
Woods, W. G., Gao, R.-N., Shuster, J. J., Robison, L. L., Bernstein, M., Weitzman, S., Bunin, G., Levy, I., Brossard, J., Dougherty, G., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012387 · Cited by 356
Meitar, D., Crawford, S. E., Rademaker, A. W., & Cohn, S. L. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.2.405 · Cited by 342
Mutation and cancer: neuroblastoma and pheochromocytoma.
Knudson, A. G., & Strong, L. C. (1972) · PubMed · Cited by 341
Norris, M. D., Bordow, S. B., Marshall, G. M., Haber, P. S., Cohn, S. L., & Haber, M. (1996) · New England Journal of Medicine · doi:10.1056/nejm199601253340405 · Cited by 322
Hempstead, B. (2002) · Current Opinion in Neurobiology · doi:10.1016/s0959-4388(02)00321-5 · Cited by 321
Sidell, N., Altman, A., Haussler, M. R., & Seeger, R. C. (1983) · Experimental Cell Research · doi:10.1016/0014-4827(83)90184-2 · Cited by 318
Chromosome localization in normal human cells and neuroblastomas of a gene related to c-myc
Schwab, M., Varmus, H. E., Bishop, J. M., Grzeschik, K.-H., Naylor, S. L., Sakaguchi, A. Y., Brodeur, G., & Trent, J. (1984) · Nature · doi:10.1038/308288a0 · Cited by 313
Self-citationApoptosis and cancer chemotherapy
Makin, G., & Dive, C. (2001) · Trends in Cell Biology · doi:10.1016/s0962-8924(01)02124-9 · Cited by 297
Bcl-2 inhibits chemotherapy-induced apoptosis in neuroblastoma.
Dole, M. G., Núñez, G., Merchant, A. K., Maybaum, J., Rode, C. K., Bloch, C. A., & Castle, V. P. (1994) · PubMed · Cited by 277
Cytoplasmic Sequestration of Wild-Type p53 Protein Impairs the G 1 Checkpoint after DNA Damage
Moll, U. M., Ostermeyer, A. G., Haladay, R., Winkfield, B., Frazier, M., & Zambetti, G. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.3.1126 · Cited by 277
Infant Cancer in the U.S.: Histology-Specific Incidence and Trends, 1973 to 1992
Gurney, J. G., Ross, J. A., Wall, D. A., Bleyer, W. A., Severson, R. K., & Robison, L. L. (1997) · Journal of Pediatric Hematology/Oncology · doi:10.1097/00043426-199709000-00004 · Cited by 276
Castle, V. P., Heidelberger, K. P., Bromberg, J., Ou, X., Dole, M. G., & Núñez, G. (1993) · PubMed · Cited by 253
Yu, A. L., Uttenreuther-Fischer, M. M., Huang, C. S., Tsui, C. C., Gillies, S. D., Reisfeld, R. A., & Kung, F. H. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.6.2169 · Cited by 250
Schmidt, M. L., Lukens, J. N., Seeger, R. C., Brodeur, G. M., Shimada, H., Gerbing, R. B., Stram, D. O., Perez, C., Haase, G. M., & Matthay, K. K. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.6.1260 · Cited by 241
Self-citationCRAWFORD, J. (1974) · The Lancet · doi:10.1016/s0140-6736(74)92370-8 · Cited by 239
Biology and Genetics of Human Neuroblastomas
Brodeur, G. M., Maris, J. M., Yamashiro, D. J., Hogarty, M. D., & White, P. S. (1997) · Journal of Pediatric Hematology/Oncology · doi:10.1097/00043426-199703000-00001 · Cited by 236
Self-citationLoss of p53 function confers high-level multidrug resistance in neuroblastoma cell lines.
Keshelava, N., Zuo, J. J., Chen, P., Waidyaratne, S. N., Luna, M. C., Gomer, C. J., Triche, T. J., & Reynolds, C. P. (2001) · PubMed · Cited by 232
A population-based study of the usefulness of screening for neuroblastoma
Woods, W. G., Tuchman, M., Robison, L. L., Bernstein, M., Leclerc, J.-M., Brisson, L. C., Brossard, J., Hill, G., Shuster, J., Luepker, R., et al. (1996) · The Lancet · doi:10.1016/s0140-6736(96)06020-5 · Cited by 231
Resistance to chemotherapy mediated by TrkB in neuroblastomas.
Ho, R., Eggert, A., Hishiki, T., Minturn, J. E., Ikegaki, N., Foster, P., Camoratto, A. M., Evans, A. E., & Brodeur, G. M. (2002) · PubMed · Cited by 228
Self-citationMatthay, K. K., DeSantes, K., Hasegawa, B., Huberty, J., Hattner, R. S., Ablin, A., Reynolds, C. P., Seeger, R. C., Weinberg, V. K., & Price, D. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.1.229 · Cited by 222
Inverse relationship between trk expression and N-myc amplification in human neuroblastomas.
Nakagawara, A., Arima, M., Azar, C. G., Scavarda, N. J., & Brodeur, G. M. (1992) · PubMed · Cited by 219
Self-citationGm, B., Hayes, F. A., Green, A. A., Casper, J., Wasson, J., Wallach, S., & Seeger, R. C. (1987) · PubMed · Cited by 215
Bcl-xL is expressed in neuroblastoma cells and modulates chemotherapy-induced apoptosis.
Dole, M. G., Jasty, R., Cooper, M. J., Thompson, C. B., Núñez, G., & Castle, V. P. (1995) · PubMed · Cited by 214
Kogner, P., Barbany, G., Dominici, C., Castello, M. A., Raschellà, G., & Persson, H. (1993) · PubMed · Cited by 207
Absence of p53 gene mutations in primary neuroblastomas.
Vogan, K. J., Bernstein, M. L., Leclerc, J., Brisson, L., Brossard, J., Brodeur, G. M., Pelletier, J., & Gros, P. (1993) · PubMed · Cited by 196
Self-citationMatsumoto, K., Wada, R. K., Yamashiro, J. M., Kaplan, D., & Cj, T. (1995) · PubMed · Cited by 193
Ponzoni, M., Bocca, P., Chiesa, V., DeCensi, A., Pistoia, V., Raffaghello, L., Rozzo, C., & Montaldo, P. G. (1995) · PubMed · Cited by 192
Lack of High-Affinity Nerve Growth Factor Receptors in Aggressive Neuroblastomas
Suzuki, T., Bogenmann, E., Shimada, H., Stram, D., & Seeger, R. C. (1993) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/85.5.377 · Cited by 187
Molecular biology and genetics of human neuroblastoma
Brodeur, G. M., & Fong, C.-T. (1989) · Cancer Genetics and Cytogenetics · doi:10.1016/0165-4608(89)90243-4 · Cited by 183
Self-citationCaron, H. N. (1995) · Medical and Pediatric Oncology · doi:10.1002/mpo.2950240402 · Cited by 175
Evidence for the development of p53 mutations after cytotoxic therapy in a neuroblastoma cell line
Tweddle, D. A., Malcolm, A. J., Bown, N. P., Pearson, A. D. J., & Lunec, J. (2001) · PubMed · doi:10.25405/ncl.34600449 · Cited by 174
Genetic parameters of neuroblastomas
Westermann, F., & Schwab, M. (2002) · Cancer Letters · doi:10.1016/s0304-3835(02)00199-4 · Cited by 173
Antisense oligonucleotides as therapeutic agents
Galderisi, U., Cascino, A., & Giordano, A. (1999) · Journal of Cellular Physiology · doi:10.1002/(sici)1097-4652(199911)181:2<251::aid-jcp7>3.0.co;2-d · Cited by 167
Neurofibromatosis type 1 gene mutations in neuroblastoma
The, I., Murthy, A. E., Hannigan, G. E., Jacoby, L. B., Menon, A. G., Gusella, J. F., & Bernards, A. (1993) · Nature Genetics · doi:10.1038/ng0193-62 · Cited by 165
Spontaneous regression of neuroblastoma.
Evans, A. E., Gerson, J. N., & Schnaufer, L. (1976) · PubMed · Cited by 162
Maris, J. M., Weiss, M. J., Guo, C., Gerbing, R. B., Stram, D. O., White, P. S., Hogarty, M. D., Sulman, E. P., Thompson, P. M., Lukens, J. N., et al. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.9.1888 · Cited by 162
Self-citationHANN, H.-W. L., Evans, A. E., Siegel, S. E., Wong, K. Y., Sather, H. N., Dalton, A., Hammond, D., & Seeger, R. C. (1985) · PubMed · Cited by 160
Prognostic significance of MYCN oncogene expression in childhood neuroblastoma.
Bordow, S. B., Norris, M. D., Haber, P. S., Marshall, G. M., & Haber, M. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.10.3286 · Cited by 159
Johnson, M. R., Look, A. T., DeClue, J. E., Valentine, M. B., & Lowy, D. R. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.12.5539 · Cited by 151
Turner, J. (1974) · PubMed · Cited by 149
Familial neuroblastoma. Case reports, literature review, and etiologic considerations
Kushner, B. H., Gilbert, F., & Helson, L. (1986) · Cancer · Cited by 148
Erdreich‐Epstein, A., Shimada, H., Groshen, S. G., Liu, M., Metelitsa, L. S., Kim, K., Stins, M. F., Seeger, R. C., & Durden, D. L. (2000) · PubMed · Cited by 148
Neurotrophins in Cell Survival/Death Decisions
Casaccia‐Bonnefil, P., Gu, C., & Chao, M. V. (1999) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-4685-6_22 · Cited by 145
Yanik, G. A., Levine, J. E., Matthay, K. K., Sisson, J. C., Shulkin, B. L., Shapiro, B., Hubers, D., Spalding, S., Braun, T., Ferrara, J. L. M., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.08.124 · Cited by 137
3F8 monoclonal antibody treatment of patients with stage 4 neuroblastoma: a phase II study.
Cheung, N. V., Kushner, B. H., Yeh, S. D. J., & Larson, S. M. (1998) · International Journal of Oncology · doi:10.3892/ijo.12.6.1299 · Cited by 122
Non-syntenic amplification of MDM2 and MYCN in human neuroblastoma.
Corvi, R., Savelyeva, L., Breit, S., et al. (1995) · PubMed · Cited by 119
Nakagawara, A., Nakamura, Y., Ikeda, H., Hiwasa, T., Kuida, K., Su, M. S. S., Zhao, H., Cnaan, A., & Sakiyama, S. (1997) · PubMed · Cited by 117
Differentiating agents in pediatric malignancies: Retinoids in neuroblastoma
Reynolds, C. P. (2000) · Current Oncology Reports · doi:10.1007/s11912-000-0104-y · Cited by 113
Constitutional 1p36 deletion in a child with neuroblastoma.
Biegel, J. A., White, P. S., Marshall, H. N., Fujimori, M., Zackai, E. H., Scher, C. D., Brodeur, G. M., & Emanuel, B. S. (1993) · PubMed · Cited by 112
Self-citationNeurotrophin receptor structure and interactions
Yano, H., & Chao, M. V. (2000) · Pharmaceutica Acta Helvetiae · doi:10.1016/s0031-6865(99)00036-9 · Cited by 108
The natural history of neuroblastic cells in the fetal adrenal gland.
Turkel, S. B., & Itabashi, H. H. (1974) · PubMed · Cited by 107
DETECTION OF A TUMOUR-ASSOCIATED GANGLIOSIDE IN PLASMA OF PATIENTS WITH NEUROBLASTOMA
Ladisch, S., & Wu, Z. (1985) · The Lancet · doi:10.1016/s0140-6736(85)91906-3 · Cited by 106
Goldman, S. C., CHEN, C.-Y., Lansing, T. J., Gilmer, T. M., & Kastan, M. (1996) · Europe PMC (PubMed Central) · Cited by 97
Deletion of chromosome 11 and of 14q sequences in neuroblastoma
Srivatsan, E. S., Ying, K. L., & Seeger, R. C. (1993) · Genes Chromosomes and Cancer · doi:10.1002/gcc.2870070106 · Cited by 97
MYCN protein expression as a predictor of neuroblastoma prognosis.
Chan, H. S. L., Gallie, B. L., DeBoer, G., Haddad, G., Ikegaki, N., Dimitroulakos, J., Yeger, H., & Ling, V. W. T. (1997) · PubMed · Cited by 97
Moley, J. F., Brother, M. B., Wells, S. A., Spengler, B. A., Biedler, J. L., & Brodeur, G. M. (1991) · PubMed · Cited by 93
Self-citationShohet, J. M., Hicks, M. J., Plon, S. E., Burlingame, S. M., Stuart, S. G., Chen, S., Brenner, M. K., & Nuchtern, J. G. (2002) · PubMed · Cited by 91
Łastowska, M., Nacheva, E. P., McGuckin, A. G., Curtis, A., Grace, C. D., Pearson, A. D. J., & Bown, N. P. (1997) · PubMed · Cited by 90
Low frequency of the p53 gene mutations in neuroblastoma
Hosoi, G., Hara, J., Okamura, T., Osugi, Y., Ishihara, S., Fukuzawa, M., Okada, A., Okada, S., & Tawa, A. (1994) · Cancer · Cited by 86
Congenital neuroblastoma, neuroblastoma in situ, and the normal fetal development of the adrenal
Ikeda, Y., Lister, J., Bouton, J. M., & Büyükpamukçu, M. (1981) · Journal of Pediatric Surgery · doi:10.1016/0022-3468(81)90019-1 · Cited by 86
Rydén, M., Sehgal, R., Dominici, C., Fh, S., Ibáñez, C. F., & Kogner, P. (1996) · British Journal of Cancer · doi:10.1038/bjc.1996.435 · Cited by 85
The Angiogenesis Inhibitor TNP-470 Reduces the Growth Rate of Human Neuroblastoma in Nude Rats
Wassberg, E., Påhlman, S., Westlin, J., & Christofferson, R. H. B. (1997) · Pediatric Research · doi:10.1203/00006450-199703000-00004 · Cited by 85
Antitumor activity of CEP-751 (KT-6587) on human neuroblastoma and medulloblastoma xenografts.
Evans, A. E., Kisselbach, K. D., Yamashiro, D. J., Ikegaki, N., Camoratto, A. M., Dionne, C. A., & Brodeur, G. M. (1999) · PubMed · Cited by 85
Self-citationEvidence for a hereditary neuroblastoma predisposition locus at chromosome 16p12-13.
Maris, J. M., Weiss, M. J., Mossé, Y. P., Hii, G., Guo, C. H., White, P. S., Hogarty, M. D., Mirensky, T. L., Brodeur, G. M., Rebbeck, T. R., et al. (2002) · PubMed · Cited by 80
Self-citationComprehensive analysis of chromosome 1p deletions in neuroblastoma
Maris, J. M., Guo, C. H., Blake, D., White, P. S., Hogarty, M. D., Thompson, P. M., Rajalingam, V., Gerbing, R. B., Stram, D. O., Matthay, K. K., et al. (2001) · Medical and Pediatric Oncology · Cited by 77
Self-citationTanaka, T., Slamon, D. J., Shimoda, H., Waki, C., Kawaguchi, Y., Tanaka, Y., & Ida, N. (1988) · PubMed · Cited by 76
Corvi, R., Amler, L. C., Savelyeva, L., Gehring, M., & Schwab, M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.12.5523 · Cited by 75
Kogon, M. M., Biswas, A., Pearl, D., Carlson, R. W., & Spiegel, D. (1997) · Cancer · doi:10.1002/(sici)1097-0142(19970715)80:2<317::aid-cncr21>3.0.co;2-w · Cited by 74
The MEIS1 Oncogene Is Highly Expressed in Neuroblastoma and Amplified in Cell Line IMR32
Spieker, N., Sluis, P. V., Beitsma, M. M., Boon, K., van Schaik, B. D. C., van Kampen, A. H. C., Caron, H. N., & Versteeg, R. (2001) · Genomics · doi:10.1006/geno.2000.6408 · Cited by 71
Induction of apoptosis by p75 neurotrophin receptor in human neuroblastoma cells
Bunone, G., Mariotti, A., Compagni, A., Morandi, E., & Valle, G. D. (1997) · Oncogene · doi:10.1038/sj.onc.1200972 · Cited by 71
Mechanism and relevance of ploidy in neuroblastoma
Kaneko, Y., & Knudson, A. G. (2000) · Genes Chromosomes and Cancer · Cited by 69
Role of neurotrophins and their receptors in human neuroblastomas: a primary culture study
Nakagawara, A., & Brodeur, G. M. (1997) · European Journal of Cancer · doi:10.1016/s0959-8049(97)00280-3 · Cited by 67
Self-citationThompson, P. M., Maris, J. M., Hogarty, M. D., Seeger, R. C., Reynolds, C. P., Brodeur, G. M., & White, P. S. (2001) · PubMed · Cited by 65
Self-citationBauer, A., Savelyeva, L., Claas, A., Praml, C., Berthold, F., & Schwab, M. (2001) · Genes Chromosomes and Cancer · doi:10.1002/gcc.1139 · Cited by 65
Katzenstein, H. M., RADEMAKER, A. W., Senger, C., Salwen, H. R., Nguyen, N. N., Thorner, P. S., Litsas, L., & Cohn, S. L. (1999) · PubMed · Cited by 62
Caron, H. N., Spieker, N., Godfried, M. B., Veenstra, M., Sluis, P. V., de Kraker, J., Voûte, P. A., & Versteeg, R. (2000) · Genes Chromosomes and Cancer · doi:10.1002/1098-2264(200102)30:2<168::aid-gcc1072>3.0.co;2-e · Cited by 61
van Limpt, V., Chan, A., Caron, H. N., Sluis, P. V., Boon, K., Hermus, M.-C., & Versteeg, R. (2000) · Medical and Pediatric Oncology · doi:10.1002/1096-911x(20001201)35:6<554::aid-mpo13>3.0.co;2-r · Cited by 61
Breakpoint position on 17q identifies the most aggressive neuroblastoma tumors
Łastowska, M., Cotterill, S. J., Bown, N. P., Cullinane, C., Variend, S., Lunec, J., Strachan, T., Pearson, A. D. J., & Jackson, M. S. (2002) · Genes Chromosomes and Cancer · doi:10.1002/gcc.10089 · Cited by 60
Comparison of 13-cis-retinoic acid to trans-retinoic acid using human neuroblastoma cell lines.
Reynolds, C. P., Schindler, P., Jones, D. M., Gentile, J., Proffitt, R. T., & Einhorn, P. A. (1994) · PubMed · Cited by 60
Kawamata, N., Seriu, T., Koeffler, H. P., & Bartram, C. R. (1996) · Cancer · doi:10.1002/(sici)1097-0142(19960201)77:3<570::aid-cncr21>3.0.co;2-0 · Cited by 55
Evidence that the MYCN oncogene regulates MRP gene expression in neuroblastoma
Norris, M. D., Bordow, S. B., Haber, P., Marshall, G. M., Kavallaris, M., Madafiglio, J., Cohn, S. L., Salwen, H. R., Schmidt, M. L., Hipfner, D. R., et al. (1997) · European Journal of Cancer · doi:10.1016/s0959-8049(97)00284-0 · Cited by 54
Human neuroblastoma cell lines that express N-myc without gene amplification
Wada, R. K., Seeger, R. C., Brodeur, G. M., Einhorn, P. A., Rayner, S. A., Tomayko, M. M., & Reynolds, C. P. (1993) · Cancer · doi:10.1002/1097-0142(19931201)72:11<3346::aid-cncr2820721134>3.0.co;2-e · Cited by 51
Self-citationRoy, N. V., Forus, A., Myklebost, O., Cheng, N. C., Versteeg, R., & Speleman, F. (1995) · Cancer Genetics and Cytogenetics · doi:10.1016/0165-4608(95)00034-m · Cited by 47
Oue, T., Fukuzawa, M., Kusafuka, T., Kohmoto, Y., Imura, K., Nagahara, S., & Okada, A. (1996) · Journal of Pediatric Surgery · doi:10.1016/s0022-3468(96)90009-3 · Cited by 47
No CDKN2 mutations in neuroblastomas.
Beltinger, C. P., White, P. S., Sulman, E. P., Maris, J. M., & Brodeur, G. M. (1995) · PubMed · Cited by 44
Self-citationDistinct response of experimental neuroblastoma to combination antiangiogenic strategies
Kim, E. S., Soffer, S. Z., Huang, J., McCrudden, K. W., Yokoi, A., Manley, C. A., Middlesworth, W., Kandel, J. J., & Yamashiro, D. J. (2002) · Journal of Pediatric Surgery · doi:10.1053/jpsu.2002.30855 · Cited by 43
Lack of Antitumor Activity of Recombinant Endostatin in a Human Neuroblastoma Xenograft Model
Jouanneau, E., Alberti, L., Nejjari, M., Treilleux, I., Vilgrain, I., Duc, A., Combaret, V., Favrot, M., Leboulch, P., & Bachelot, T. (2001) · Journal of Neuro-Oncology · doi:10.1023/a:1006420200626 · Cited by 41
Truckenmiller, M. E., Vawter, M. P., Cheadle, C., Coggiano, M. A., Donovan, D. M., Freed, W. J., & Becker, K. G. (2001) · PubMed · Cited by 36
Roy, N. V., Laureys, G., Gele, M. V., et al. (1997) · European Journal of Cancer · doi:10.1016/s0959-8049(97)00319-5 · Cited by 35
Iolascon, A., Giordani, L., Moretti, A., Tonini, G. P., Cunsolo, C. L., Mastropietro, S., Borriello, A., & Ragione, F. D. (1998) · Pediatric Research · doi:10.1203/00006450-199801000-00021 · Cited by 33
Hoshi, M., Otagiri, N., Shiwaku, H., Asakawa, S., Shimizu, N., Kaneko, Y., Ohi, R., Hayashi, Y., & Horii, A. (2000) · British Journal of Cancer · doi:10.1054/bjoc.2000.1108 · Cited by 32
Role of Apoptosis in Human Neuroblastomas
Brodeur, G. M., & Castle, V. P. (1999) · Humana Press eBooks · doi:10.1007/978-1-59259-720-8_20 · Cited by 5
Self-citation
Cited by
Cancer Metastasis: Building a Framework
Gupta, G. P., & Massagué, J. (2006) · Cell · doi:10.1016/j.cell.2006.11.001 · Cited by 4,247
Maris, J. M., Hogarty, M. D., Bagatell, R., & Cohn, S. L. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60983-0 · Cited by 2,032
The International Neuroblastoma Risk Group (INRG) Classification System: An INRG Task Force Report
Cohn, S. L., Pearson, A. D. J., London, W. B., Monclair, T., Ambros, P. F., Brodeur, G. M., Faldum, A., Hero, B., Iehara, T., Machin, D., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.16.6785 · Cited by 1,910
Self-citationLiquid biopsy: monitoring cancer-genetics in the blood
Crowley, E., Di Nicolantonio, F., Loupakis, F., & Bardelli, A. (2013) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2013.110 · Cited by 1,819
Somatic and germline activating mutations of the ALK kinase receptor in neuroblastoma
Janoueix-Lerosey, I., Lequin, D., Brugières, L., Ribeiro, A., de Pontual, L., Combaret, V., Raynal, V., Puisieux, A., Schleiermacher, G., Pierron, G., et al. (2008) · Nature · doi:10.1038/nature07398 · Cited by 894
Metadata
- Authors
- Brodeur, G. M.
- Venue
- Nature Reviews Cancer
- Published
- 2003-03
- Volume
- 3
- Issue
- 3
- Pages
- 203-216
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W2067606868
- Cited by
- 2,160
- References
- 126
- FWCI
- 9.49
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.